SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

DOGI is gaining traction as a prominent DRC-20 token on the Dogecoin network, with the community highlighting its ecosystem growth, potential utility from trading bots, and upcoming platform developments. Investors are actively discussing the token's correlation with the broader meme coin market cycle and the rising adoption of Doginals.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a report that the company is preparing an acquisition bid for eBay, fueling intense community speculation about how a significantly smaller firm could finance such a major deal. Investors are actively debating the potential for a transformative pivot or a complex leveraged buyout, with sentiment split between high-stakes optimism for a massive squeeze and skepticism regarding the feasibility of the acquisition.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as investors react to reports of an AI-driven autonomous lab milestone achieved using OpenAI technology, which community members are debating as a potential catalyst for long-term platform scalability. While some traders are focused on short-term price volatility and bearish sentiments regarding historical performance, others remain optimistic about the company's long-term infrastructure play in the biotechnology and AI sectors.

Chip

CHIP is seeing intense retail debate as traders weigh potential utility in the AI infrastructure sector against accusations of being a pump-and-dump scheme. The community is sharply divided, with some betting on a short squeeze and long-term holding based on upcoming token unlocks, while others cite high supply dilution and insider selling as reasons for volatility.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is drawing significant investor attention after confirming the receipt of nearly $700 million in federal tax refunds, a cash injection that analysts note exceeds the company's current market capitalization. Community discourse is heavily focused on the stock's potential for a massive short squeeze, with many users highlighting the high short interest and improved balance sheet liquidity as catalysts for a potential rally.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as members of the community weigh in on its recent performance, with active debates centered on long-term institutional utility and the potential for a recovery toward previous price levels. While some traders express frustration over extended price declines, others remain focused on technical signals and fundamental developments, frequently highlighting the network's quantum-resistant architecture and ongoing ecosystem adoption.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as investors react to a mix of strong Q4 marketplace growth and recent volatility fueled by analyst price target adjustments and debates over the impact of AI-driven delivery disruption. Community sentiment remains polarized, with active discussions focusing on the long-term sustainability of gig economy margins and whether recent analyst downgrades create a potential buying opportunity.

iShares Trust - iShares U.S. Aerospace & Defense ETF

iShares Dow Jones US Aerospace & Defense

The iShares Dow Jones US Aerospace & Defense ETF (ITA) is trending as ongoing geopolitical conflicts and shifts in defense spending keep the sector in focus for investors. The community is actively debating the potential long-term benefits of holding defense-oriented ETFs amidst persistent military demand and global supply chain challenges.

Pump.fun

Pump.fun is generating significant community conversation as traders weigh its rapid memecoin deployment against concerns over volatility and sustainability. While some participants are actively participating in buyback campaigns and promoting new projects on the platform, others remain skeptical due to the high volume of rapid token turnover and common market risks.

Based is a financial superapp built on Hyperliquid that lets users trade crypto, equities, and commodities from a single interface, fund accounts directly from bank accounts or credit cards, and spend balances at over 100 million merchants worldwide using a Visa Platinum card that converts at the point of sale with no separate off-ramp required. The platform operates across web, iOS, Android, and desktop with one account, and includes features like curated Launchpools for early project access and AI-native wallets for autonomous trading and risk monitoring.

Based Token

BASED is currently seeing active debate within the community as investors weigh its potential as a 'crypto super app' against significant volatility and concerns over leveraged trading patterns. While bulls point to technical indicators and the app's utility as signs of long-term upside, others remain skeptical, citing recurring sell-offs and warning against short-term price manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>AKAN is also on track for its best week ever with gains of 300% so far.</li><li>Investor sentiment across cannabis stocks improved after the U.S. Justice Department moved state-regulated marijuana toward Schedule III.</li><li>AKAN’s rally was amplified by its tiny public float of about 534,420 shares, following multiple reverse stock splits.</li></ul>Shares of Akanda Corp. (AKAN) delivered one of the biggest rallies in April among cannabis stocks, rocketing 1,700% and sharply outperforming peers as traders targeted the micro-float stock during a policy-driven sector rebound.<a href="https://stocktwits.com/symbol/AKAN">AKAN stock</a> outperformed cannabis peers, including&nbsp;<a href="https://stocktwits.com/symbol/TCNNF">Trulieve Cannabis (TCNNF)</a>, up 94%;&nbsp;<a href="https://stocktwits.com/symbol/CGC">Canopy Growth Corp. (CGC)</a>, up 30%;&nbsp;<a href="https://stocktwits.com/symbol/IGC">IGC Pharma (IGC)</a>, up 25%; and&nbsp;<a href="https://stocktwits.com/symbol/ACB">Aurora Cannabis (ACB)</a>, up 12%, over the past month. AKAN is also poised to log its best week ever,&nbsp;having more than quadrupled as of Thursday’s close.&nbsp;<img src="https://news.stocktwits-cdn.com/koyfin_20260501_083616528_png_777b15d360.webp" alt="koyfin_20260501_083616528.png"><h2 class="st-heading-2">Tiny Float, Higher Buzz For AKAN</h2>Investor sentiment for cannabis stocks got a boost after the U.S. government moved state-regulated marijuana from Schedule I toward Schedule III, pushing increased medical research access, tax treatment clarity, and regulatory legitimacy.The change revived optimism across the medical cannabis sector, with traders rotating into smaller stocks, which have exposure to future regulatory tailwinds. Akanda had previously welcomed U.S. rescheduling efforts in December, keeping the company relevant in the segment.The company operates a hemp platform focused on expanding access to medicinal-grade cannabis, CBD, and wellness products across legal markets. THC, or tetrahydrocannabinol, is the part of cannabis that produces the “high” and is therefore more tightly regulated, while CBD, or cannabidiol, does not cause intoxication and is widely used in medical and wellness treatments.&nbsp;The company implemented a 1-for-3.125 reverse stock split last year, followed by a more recent 1-for-5 reverse stock split in January. A further reverse split adjustment last month reduced its total float to 534,420 shares. Short levels for the stock currently stand at 4.7%, its highest levels in four months.&nbsp;Meanwhile, cannabis peers such as TLRY have a float of 119.28 million shares, CGC about 380.82 million, and CRON nearly 379.05 million. The comparatively tiny supply made AKAN shares more sensitive to buying pressure amid April’s cannabis rally.<h2 class="st-heading-2">Canada Cultivation Plans Take Root</h2>Akanda’s main cannabis asset is its Gabriola Island cultivation site in British Columbia, where the company currently operates under a hemp cultivation license, while working toward a full THC cultivation license covering cannabis flower and derivative products. In October, the company extended its option on the property for an additional two years.The pot firm has also been evaluating Health Canada-aligned security infrastructure requirements, including improved perimeter controls, surveillance systems, access management, and secure storage measures needed in licensing inspections for THC and CBD activities. Commercial THC production has not yet begun at the site.Akanda also exited its earlier African cultivation exposure after operations at its former unit in Lesotho ceased following an unauthorized liquidation ordered by the High Court of Lesotho in 2022, after which Akanda moved away from the region. It later discontinued operations at its Canmart distribution unit in the UK last year, citing licensing renewal costs and litigation exposure that outweighed expected near-term revenues.<h2 class="st-heading-2">Telecom Pivot Adds A Safety Net</h2>Akanda has also been gradually refocusing its strategy more heavily on Canada and Europe, while building a parallel telecommunications infrastructure platform through its unit, First Towers &amp; Fiber, in Mexico.&nbsp;As part of the pivot, the company has been expanding its dark-fiber network footprint across Central Mexico, including a recent addition of about 200 kilometers of infrastructure, which is expected to generate $2 million in contracted cash flow over 10 years. The move into telecom has added a source of contract-based income alongside Akanda’s medical cannabis business, providing investors with a potential hedge against the typical volatility in pure-cannabis companies.&nbsp;<h2 class="st-heading-2">How Do Retail Traders Feel About AKAN?</h2>On Stocktwits, retail sentiment for AKAN was ‘extremely bullish’ amid an eye-watering 231,800% surge in message volumes over the past month.<figure class="image"><img src="https://news.stocktwits-cdn.com/akan_ss_png_05e51e83c2.webp" alt="akan ss.png" width="974" height="140"><figcaption>AKAN sentiment and message volume as of April 30 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Stinkypoopypants/message/651947797">said</a>, “This is a low float that can run as high as it’s pushed. Shorts will have to cover at some point. Yes it will go down but the real question is how high can we push it?”<stembedurl>https://stocktwits.com/Stinkypoopypants/message/651947797</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/_MarginOfSanity_/message/651968893">said</a>, “Fundamentals don’t matter in a short squeeze. It’s just math. Limited supply meets infinite demand.”<stembedurl>https://stocktwits.com/_MarginOfSanity_/message/651968893</stembedurl>AKAN stock has jumped 376% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asts-rklb-fly-lunr-stocks-rally-fcc-satellite-broadband-spectrum-rule/cZQNqL1ReIK">ASTS, RKLB, FLY, LUNR Stocks Rally As FCC Opens Door To Faster Satellite Broadband Networks</a>

AKAN stock has jumped 376% over the past year. Photo credit: Getty Images

AKAN Stock Leaves Cannabis Peers In The Smoke With A Stunning 1,700% Rally In April — What’s Fueling The Run?

The company’s primary cannabis asset remains its Gabriola Island cultivation site in British Columbia, where it operates under a hemp license.

Equity

<ul class="summary-bullets"><li>Since the marijuana reclassification move, AKAN stock has significantly outperformed peers Tilray, Canopy Growth, and Aurora Cannabis.</li><li>The regulatory shift on marijuana is expected to provide tax relief for licensed operators and support research.</li><li>AKAN stock is set to test the 200-DMA for the first time since October 2025.</li></ul>Shares of Akanda Corp (AKAN) are once again on a tear, surging 32% in pre-market trading on Thursday, yet even that sharp move would rank only as its fourth-biggest single-day gain this year if it holds at close.The latest pre-market jump extends a powerful two-day rally that has sent AKAN shares soaring about 114%, putting the stock on track to test its 200-day moving average for the first time since Oct. 1, 2025.<a href="https://stocktwits.com/symbol/AKAN">AKAN shares</a> recorded their best-ever single-day gains after news of marijuana reclassification broke earlier this month.&nbsp;The stock has rallied nearly 700% in the six sessions since then through Wednesday’s close.<h2 class="st-heading-2">What Triggered The Breakout Rally?</h2>The U.S. Department of Justice moved to <a href="https://stocktwits.com/news-articles/markets/equity/tlry-cgc-acb-msos-pare-early-gains-after-marijuana-reclassification-retail-says-weed-industry-is-reborn/cZBfz1nReRK">reclassify</a> medical marijuana as a less dangerous drug, following an executive order from President Donald Trump. The change moves it from Schedule I to Schedule III under the Controlled Substances Act.While the change does not legalize marijuana, it is expected to ease regulations, provide tax relief for licensed operators, and support research. Officials said the update will also speed up rulemaking, expand access to medical treatments, and strengthen oversight of medical marijuana programs across the U.S.<h2 class="st-heading-2">What Are Retail Traders Saying?</h2>AKAN shares have been under the spotlight for a while, with message volumes on Stocktwits exceeding a massive 106,200% over a 30-day period. Retail sentiment has remained in the ‘extremely bullish’ territory over the time period.One user expects the stock to climb to triple digits. It is currently trading at $35.<stembedurl>https://stocktwits.com/momoneyinfla/message/651829518</stembedurl>Another user said the movement doesn’t seem like a “pump and dump” scheme.<stembedurl>https://stocktwits.com/Wowsuchboolish/message/651836014</stembedurl>Since the marijuana reclassification move, AKAN stock has significantly outperformed Tilray (TLRY), which has lost around 8%, Canopy Growth (CGC), down around 4%, and Aurora Cannabis (ACB), also down around 8%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

AKAN Stock Surges 32% Pre-Market – But Still Trails Its Largest Single-Day Rally This Year

The DOJ reclassified marijuana from a Schedule I to a Schedule III drug last week.

This Cannabis Stock’s 700% Run In A Week Has Retail Traders Eyeing Triple Digits

Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets PR Newswire EDMONTON, AB, April 28, 2026 NASDAQ | TSX: ACBQ1 launches reinforce...

Top Cannabis Stocks To Follow Now - April 27th

Tilray Brands, Akanda, Canopy Growth, Quantum Biopharma, and Aurora Cannabis are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of companies with significant business activities tied to the cannabis plant including cultivation, p...

Aurora Cannabis (OTCMKTS:ACBFF) Trading Down 13.7% - Here's Why

Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 13.7% - Should You Sell...

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry

Trump has also called on Congress to preserve access to full-spectrum CBD products and expand research.

Aurora Cannabis (TSE:ACB) Stock Price Down 5.5% - Here's Why

Aurora Cannabis (TSE:ACB) Shares Down 5.5% - Here's What Happened...

<ul class="summary-bullets"><li>The change does not legalize marijuana but reduces regulatory hurdles and offers tax relief for licensed operators.</li><li>Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.</li><li>The DOJ is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III.</li></ul>Shares of Tilray (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB), and IGC Pharma Inc (IGC) remained in focus after the U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order to shift it from Schedule I to Schedule III.After rallying in the previous session and gaining in pre-market trading on Thursday, the stocks fell in morning trade. At the time of writing, TLRY, CGC, ACB and IGC fell between 2-5%.&nbsp;Meanwhile, AdvisorShares Pure US Cannabis ETF (MSOS) fell 5.5%.<h2 class="st-heading-2">DOJ To Update Rulemaking Processes For Reclassification</h2>While the change does not legalize marijuana, it reduces regulatory hurdles, offers tax relief for licensed operators, and makes research easier. Schedule III drugs are considered to have a moderate to low risk of dependence. Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana">said</a> Todd Blanche, acting Attorney General, in a statement.Separately, the Justice Department said it is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. The move is expected to expand access to medical treatments and support research, while also strengthening the legal framework for medical marijuana programs across dozens of U.S. states.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits for TLRY, CGC, ACB, and IGC turned ‘extremely bullish,’ amid ‘extremely high’ message volumes.One user said, “The weed industry is reborn.”<stembedurl>https://stocktwits.com/Lando_Calrissian/message/651131346</stembedurl>Another user said Tilray will be the “king in the U.S. cannabis market.”<stembedurl>https://stocktwits.com/Rumsen/message/651070434</stembedurl>Meanwhile, shares of nano-cap Akanda Corp. (AKAN)&nbsp;climbed 6% higher,&nbsp;extending a stunning 215% surge from the previous session, with investors and traders debating whether the explosive rally is driven by cannabis reclassification optimism or the stock’s low float.Message volumes on the Stocktwits platform for the stock surged by around 48,000% over a 24-hour period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Legalized Marijuana In Canada (Photo by Lane Turner/The Boston Globe via Getty Images)

TLRY, CGC, ACB, MSOS Pare Early Gains After Marijuana Reclassification: Retail Says ‘Weed Industry Is Reborn’

The U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order.

Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug

Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug Pot stocks are moving higher in premarket trading in New York after the Justice Department and DEA announced that...

<ul class="summary-bullets"><li>On Wednesday, TLRY jumped 14%, CGC surged 21%, and ACB gained 7%</li><li>Marijuana remains classified as a Schedule I drug under U.S. law, and a lower-risk classification would ease research barriers and improve financing access.</li><li>The expected regulatory move follows a December executive order directing a review of federal marijuana restrictions.</li></ul>Shares of Canadian cannabis producers Tilray Brands (TLRY), Canopy Growth (CGC) and Aurora Cannabis (ACB) rallied on Wednesday after reports said that the U.S. may soon reclassify marijuana, putting fresh focus on which cannabis stock stands to benefit the most from a potential regulatory breakthrough.On Wednesday,&nbsp;<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> jumped 14%,&nbsp;<a href="https://stocktwits.com/symbol/CGC">CGC shares</a> surged 21%, and&nbsp;<a href="https://stocktwits.com/symbol/ACB">ACB stock</a> gained 7%.<h2 class="st-heading-2">Cannabis Could Move Out Of Schedule I Category</h2>The highly anticipated regulatory move, reported by&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.axios.com/2026/04/22/trump-marijuana-rule-change">Axios</a>, citing an admin official familiar with the matter, could mark a major turning point for pot stocks. Marijuana is currently classified as a Schedule I drug under U.S. laws, the same category as substances such as heroin and LSD.&nbsp;The potential regulatory move follows a December executive order asking regulators to review federal marijuana restrictions. If approved, cannabis could move into a lower-risk category alongside drugs such as Ketamine and Testosterone.<h2 class="st-heading-2">ACB Tops Upside Among Cannabis Peers</h2>Consensus estimates compiled by Koyfin show that Aurora Cannabis currently carries the strongest valuation upside among the three stocks if sentiment improves following a regulatory change.&nbsp;Aurora holds a 12-month average analyst price target of $5.55, implying a 46% upside form current levels. The stock carries one ‘Strong Buy’, two ‘Buy’, and two ‘Hold’ ratings from five covering analysts.Tilray Brands carries a 12-month average analyst price target of $10.04, implying a 28% upside from the stock’s last close. Analyst sentiment includes three ‘Buy’, six ‘Hold’, and one ‘Strong Sell’ rating across ten analysts.Meanwhile, Canopy Growth has a 12-month average analyst price target of $1.72, representing a 26% upside from current levels. Coverage includes one ‘Strong Buy’, one ‘Buy’, five ‘Hold’, and one ‘Strong Sell’ rating from eight analysts.<h2 class="st-heading-2">TLRY, CGC, ACB Pursue Different Growth Plans</h2>Alongside the regulatory catalyst, the three producers are pursuing different growth strategies in global markets to boost their businesses.&nbsp;Tilray has focused on diversifying beyond cannabis, expanding its medical distribution footprint in Germany through partnerships with Tilray Medical, CC Pharma, 14U Pharma, and the Gesund leben pharmacy network.The company also acquired key U.S. BrewDog assets and, through a partnership with The Magnum Ice Cream Company, introduced Popsicle Hard beverages, while expanding its medical cannabis portfolio in Australia.On the other hand, Canopy Growth has focused on strengthening its Canadian operations, including the launch of its Deelish value brand targeting the domestic retail market. It has also agreed to acquire MTL Cannabis in a C$125 million transaction to add a profitable, adjusted-EBITDA-positive business.Meanwhile, Aurora has prioritized international medical cannabis markets, expanding its portfolio across Australia and New Zealand, securing EU plant variety rights for proprietary cultivars and launching the Daily Special medical cannabis brand in Germany as part of its export-led strategy.<h2 class="st-heading-2">How Do Retail Traders Feel About TLRY, CGC, ACB?</h2>On Stocktwits, retail sentiment for all three cannabis stocks was ‘extremely bullish’ amid ‘extremely high’ message volume.Over the past year, TLRY shares have climbed 72%, CGC has gained 17%, while ACB has declined 11%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/michael-burry-keeps-moh-bet-at-154-plans-to-buy-more/cZBfKSBRebK">‘Big Short’ Investor Michael Burry Sticks With MOH Bet At $154 — Plans To Add More Shares</a>

Over the past year, TLRY shares have climbed 72%, CGC has gained 17%, while ACB has declined 11%. (Photo credit: Getty Images)

TLRY Vs CGC Vs ACB: Which Cannabis Stock Gets The Biggest High If Regulatory Fog Clears?

Consensus estimates compiled by Koyfin suggest ACB currently offers the strongest valuation upside.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

ACB
Aurora Cannabis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACB News

ACBAurora Cannabis Inc